Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression of S100A10 knocked down human breast cancer cells

ABSTRACT: Gene expression of S100A10 knocked down human breast cancer cells

PROVIDER: PRJNA661489 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression of S100A10 knocked down human breast cancer cells

Project description:The expression level of S100A10 was much higher in the CD44+ cancer cells metastasized to the liver than those at the primary site in the breast cancer patient-derived tumor xenograft mice. Expression level of S100A10 increased by the oncoprotein, PML/RARα and RAS, and its higher expression is linked to worse outcome in a number of cancer types including breast cancers

2021-09-07 | GSE157497 | GEO

mRNA Profiling of Murine 4T1 Breast Cancer Cells with Asns knocked down

Project description:mRNA Profiling of Murine 4T1 Breast Cancer Cells with Asns knocked down

| PRJNA414245 | ENA

Gene expression profile in MCF7 breast cancer cells after 78 functionallly important molecules were knocked down using siRNA.

Project description:Affymetrix microarray data was generated from MCF7 breast cancer cells treated in vitro with siRNAs against 78 transcription factors and signalling molecules. Gene expresion of 78 functionally important molecules were knocked down in MCF7 breast cancer cells using siRNA. Then the gene expression profiles of these MCF7 cells, along with untreated cells and non-targetting control (SICONTROL) treated cells were analysed using microarrays.

2012-03-15 | E-GEOD-31912 | biostudies-arrayexpress

Gene expression by TRPS1 knocked down in T47D

Project description:Gene expression by TRPS1 knocked down in T47D

| PRJNA408130 | ENA

Isobaric tags for relative and absolute quantification based on quantitative proteomic analysis on inhibitor of apoptosis protein-like protein-2 knocked-down MCF-7 breast cancer cells

Project description:Although the inhibitor of apoptosis protein-like protein-2 (ILP-2) is regarded as a novel growth enhancer for breast cancer, its mechanism on breast cancer cell growth remains elusive and requires further study. In this study, isobaric tags were applied for relative and absolute quantification (iTRAQ) analysis on two groups of MCF-7 (Michigan Cancer Foundation-7) breast cancer cells, namely, siRNA-5 group (knocked down, KD group) and negative control (NC) group, to analyse the protein expression profiles correlated to ILP-2 during breast cancer cell growth. Western blot was applied to verify the iTRAQ data. The results indicated that a total of 4065 proteins were identified in breast cancer cells, and 241 of these proteins are differentially expressed (fold change ≥ 1.20 or ≤ 0.83 and P<0.05). A total of 156 up- and 85 down-regulated proteins are found in siRNA-5 group versus NC group. These differentially expressed proteins are principally correlated to the ECM (extracellular matrix) -receptor interaction, and the proteins from the top 10 biological processes are correlated to signal transduction, regulation of cell proliferation and immune system processes. The expression of AGA (N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase), MT1E (metallothionein-1E) and TDO2 (tryptophan 2,3-dioxygenase) increases when the protein expression of ILP-2 is knocked down. These results suggested that ILP-2 has an important role in breast cancer cell growth via protein interaction and provided comprehensive insights into biochemical pathways and regulation networks correlated to ILP-2.

2019-02-25 | PXD012848 | iProX

Gene expression profile in MCF7 breast cancer cells after siRNA knock down of estrogen receptor alpha (ESR1)

Project description:Affymetrix microarray data was generated from MCF7 breast cancer cells treated in vitro with siRNAs against estrogen receptor alpha (ESR1). Gene expresion of estrogen receptor alpha (ESR1) was knocked down in MCF7 breast cancer cells using siRNA. Then the gene expression profiles of these MCF7 cells, along with non-targetting control treated cells were analysed using Affymetrix Human Genome U133 Plus 2.0 microarrays.

2012-05-06 | E-GEOD-37820 | biostudies-arrayexpress

Gene expression by LASP1 knocked down in PC3 cells

Project description:Gene expression by LASP1 knocked down in PC3 cells

| PRJNA655418 | ENA

Gene expression by BTF3 knocked down in Vcap cells

Project description:Gene expression by BTF3 knocked down in Vcap cells

| PRJNA506234 | ENA

Gene expression of breast cancer stem cells.

Project description:Metastatic progression remains the major cause of death in human breast cancer. Cancer cells with cancer stem cell (CSC) properties drive initiation and growth of metastases at distant sites. We have previously established the breast cancer patient-derived tumor xenograft (PDX) mouse model in which CSC marker CD44+ cancer cells formed spontaneous microscopic metastases in the liver. In this PDX mouse, the expression levels of S100A10 and its family proteins were much higher in the CD44+ cancer cells metastasized to the liver than those at the primary site.

2020-12-22 | GSE151191 | GEO

The gene expression analysis of TDP knocked down MIN6 cells.

Project description:The gene expression analysis of TDP knocked down MIN6 cells.

| PRJNA516346 | ENA